Angela Orcurto
Lausanne Branch
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2025
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Journal: Science immunology
Published: February 02, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma.
Journal: Immunity
Published: August 18, 2023
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 11, 2022
Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center
Journal: Revue medicale suisse
Published: December 01, 2021
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
Journal: Cancers
Published: September 28, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Journal: Cancer discovery
Published: January 02, 2021
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
Journal: Journal for immunotherapy of cancer
Published: July 24, 2020
Last Updated: 09/26/2026